Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2016 2
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors and treatment for recurrent vulvar squamous cell carcinoma.
Nooij LS, Brand FA, Gaarenstroom KN, Creutzberg CL, de Hullu JA, van Poelgeest MI. Nooij LS, et al. Crit Rev Oncol Hematol. 2016 Oct;106:1-13. doi: 10.1016/j.critrevonc.2016.07.007. Epub 2016 Jul 25. Crit Rev Oncol Hematol. 2016. PMID: 27637349 Free article. Review.
Currently, wide local excision is the treatment of choice for local recurrences. Isolated local recurrence of VSCC has a good prognosis, with reported 5-year survival rates of up to 60%. Groin recurrences and distant recurrences are less common and have an extremely poor …
Currently, wide local excision is the treatment of choice for local recurrences. Isolated local recurrence of VSCC has a good prognosis …
Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma.
Castelnau-Marchand P, Escande A, Mazeron R, Bentivegna E, Cavalcanti A, Gouy S, Baratiny C, Maroun P, Morice P, Haie-Meder C, Chargari C. Castelnau-Marchand P, et al. Brachytherapy. 2017 May-Jun;16(3):518-525. doi: 10.1016/j.brachy.2017.01.005. Epub 2017 Mar 3. Brachytherapy. 2017. PMID: 28262516
CONCLUSIONS: Interstitial BT used as part of the primary or postoperative treatment of vulvar carcinoma is feasible with a satisfactory toxicity profile. Prognosis remains, however, dismal, with a high frequency of failures in patients with locally advanced tumors....
CONCLUSIONS: Interstitial BT used as part of the primary or postoperative treatment of vulvar carcinoma is feasible with a satisfactory toxi …
Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer.
Han SN, Vergote I, Amant F. Han SN, et al. Int J Gynecol Cancer. 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058. Int J Gynecol Cancer. 2012. PMID: 22552830 Clinical Trial.
METHOD: A prospective, single-arm, single-center pilot study was initiated to study response rate of 9 weekly courses of paclitaxel (60 mg/m) and carboplatin (area under the curve, 2.7). ...
METHOD: A prospective, single-arm, single-center pilot study was initiated to study response rate of 9 weekly courses of paclitaxel ( …